The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $140.12

Today's change+0.44 +0.31%
Updated April 28 1:48 PM EDT. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $140.12

Today's change+0.44 +0.31%
Updated April 28 1:48 PM EDT. Delayed by at least 15 minutes.

Laboratory Corporation of America Holdings up (U.S.)$0.44

Laboratory Corporation of America Holdings is up today by (U.S.)$0.44 or 0.31% to (U.S.)$140.12. Shares have lost 2.22% over the last five days, but sit 4.44% below their 52-week high. This security has underperformed the S&P 500 by 3.25% during the last year.

Key company metrics

  • Open(U.S.) $139.50
  • Previous close(U.S.) $139.68
  • High(U.S.) $140.46
  • Low(U.S.) $139.21
  • Bid / Ask(U.S.) $140.08 / (U.S.) $140.15
  • YTD % change+9.14%
  • Volume420,275
  • Average volume (10-day)1,003,574
  • Average volume (1-month)768,531
  • Average volume (3-month)794,566
  • 52-week range(U.S.) $119.51 to (U.S.) $146.63
  • Beta0.98
  • Trailing P/E19.31×
  • P/E 1 year forward14.75×
  • Forward PEG1.74×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.26
Updated April 28 1:48 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.83%

Based on its net profit margin of 7.83%, Laboratory Corporation of America Holdings is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.63%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue2,4282,4152,4312,368
Total other revenue--------
Total revenue2,4282,4152,4312,368
Gross profit788788827777
Total cost of revenue1,6401,6261,6041,591
Total operating expense2,1052,0912,0642,066
Selling / general / administrative406401408412
Research & development--------
Depreciation / amortization49414544
Interest expense (income), net operating--------
Unusual expense (income)1023719
Other operating expenses, total--------
Operating income323324367302
Interest income (expense), net non-operating-53-58-54-55
Gain (loss) on sale of assets--------
Other--------
Income before tax277263313256
Income after tax185180199161
Income tax, total928411596
Net income184180198160
Total adjustments to net income--------
Net income before extra. items184180198160
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items184180198160
Inc. avail. to common incl. extra. items184180198160
Diluted net income184180198160
Dilution adjustment------0
Diluted weighted average shares105105104104
Diluted EPS excluding extraordinary itemsvalue per share1.761.711.911.55
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share1.831.861.951.66